net2phone Acquires Integra, an Omnichannel CCaaS Platform
March 03, 2022 17:10 ET
|
net2phone
net2phone strengthens its position as a leading provider of cloud communications and collaboration solutions Newark, NJ, March 03, 2022 (GLOBE NEWSWIRE) -- net2phone, a leading...
Dallas, Texas is the Home of Command Alkon’s Annual Spring TRAININGDAYS
February 18, 2020 10:06 ET
|
Command Alkon
BIRMINGHAM, Ala., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Command Alkon, the leading Supplier Collaboration Platform for Construction’s Heavy Work, will offer their annual Spring TRAININGDAYS Regional...
Integra Reports on Positive Metallurgical Test-work Program Ongoing at DeLamar and Florida Mountain Deposits
April 08, 2019 06:00 ET
|
Integra Resources Corp.
Press Release Highlights: Oxidation boundaries on the NI 43-101 inferred resource estimate at DeLamar and Florida Mountain are estimated at:• 24% oxide mineralization• 29% transitional...
Arch Therapeutics to Provide Corporate Update at the 2019 BIO CEO & Investor Conference
February 05, 2019 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Arch Therapeutics to Provide Corporate Update at the 11th Annual Biotech Showcase™ 2019 Conference on January 8th, 2019
December 20, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 20, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, will...
Arch Therapeutics Receives 510(k) Clearance from the US FDA for AC5™ Topical Gel
December 17, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Provided Corporate Update at the 11th Annual LD Micro Main Event
December 06, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 06, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices,...
Arch Therapeutics Announces Positive Outcome of Ruling from Japanese Intellectual Property High Court
December 04, 2018 07:50 ET
|
Arch Therapeutics, Inc.
FRAMINGHAM, Mass., Dec. 04, 2018 (GLOBE NEWSWIRE) -- Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of novel liquid, gel and solid hemostatic and wound care devices, is...
Integra Resources Intersects 1.41 g/t AuEq Over 144.78 m, incl 12.69 g/t AuEq Over 9.15 m at Delamar Deposit, Extends Sullivan Gulch Zone by 250 m in Step-Out Drilling
September 18, 2018 06:00 ET
|
Integra Resources Corp.
Press Release Highlights: Results from both step-out and infill drilling continues to confirm gold-silver mineralization continuity and future resource expansion potential to the southeast of...
Integra Resources Intercepts 2.16 g/t AuEq Over 220.98 m, Including 4.14 g/t AuEq Over 73.15 m, and 1.74 g/t AuEq Over 198.12 m in Expansion Drill Program at the DeLamar Project
June 25, 2018 04:00 ET
|
Integra Resources Corp.
Press Release Highlights: Drilling continues to intersect mineralization beyond the footprint of the DeLamar Deposit to the southeast (“SE”) of previously reported results, almost no drilling has...